Alphatec Spine, Globus Medical and NuVasive announced updates to their manufacturing strategies earlier this year. The companies have taken different...
While China's stock market volatility has disrupted global markets and fueled fears of a sliding economy, current events haven't appreciably affected the country's healthcare market and shouldn’t deter medical device investors, according to industry leaders and consultants.
Price pressure will continue to drive the orthopaedic industry's narrative in coming years as cost containment measures from public and private payors trickle through the healthcare supply chain. Executives at OMTEC 2015 offered key insight on overcoming industry's challenges.
Leaders from Smith & Nephew, Medtronic and Biomet convened for a roundtable focused on acquisition and insight that provides a glimpse of current and future movement in the orthopaedic industry.
The fracture repair market stands to remain one of the stronger orthopaedic segments over the next five years based upon its reach across all demographics.
To better understand the expanding orthopaedic markets, the OMTEC 2014 Keynote CEO Discussion sought perspective on the trends in developed and developing countries. Â Here are their thoughts.
Orthopaedic device companies that can demonstrate innovation in design and delivery, as well as efficiency in use and cost, will be best-positioned to succeed.
Large, cash-rich orthopaedic device companies have increasingly opted to acquire companies and product lines that allow for scale over focusing resources on in-house development.